SCHEMBL4348029

SCHEMBL4348029

O=C1N=C(N2CCN(c3nsnc3Cl)CC2)SC1=Cc1cccc(C(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 5/20 0.54
ALDH1A1 P00352 3/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
HTT P42858 1/20 0.50
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
DCTPP1 Q9H773 1/20 0.47
GRIN1 Q05586 3/20 0.46
GRIN2B Q13224 3/20 0.46
HDAC1 Q13547 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
MCHR1 Q99705 1/20 0.43
SENP1 Q9P0U3 1/20 0.42
AVPR1A P37288 1/20 0.42
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4358669 1.00 ENPP2 (0.54) ENPP2ALDH1A1MAPTKMT2AHTT
SCHEMBL4351665 0.91 ALDH1A1 (0.48) ENPP2ALDH1A1MAPTKMT2AHTT
SCHEMBL4346451 0.85 GRIN1 (0.56) ENPP2ALDH1A1MAPTKMT2AHTT
SCHEMBL4360872 0.85 GRIN1 (0.56) ENPP2ALDH1A1MAPTKMT2AHTT
SCHEMBL4360877 0.85 GRIN1 (0.56) ENPP2ALDH1A1MAPTKMT2AHTT
SCHEMBL4346453 0.85 GRIN1 (0.56) ENPP2ALDH1A1MAPTKMT2AHTT
SCHEMBL4356185 0.84 ENPP2 (0.43) ENPP2ALDH1A1MAPTKMT2AHTT
SCHEMBL4356182 0.84 ENPP2 (0.43) ENPP2ALDH1A1MAPTKMT2AHTT
SCHEMBL4354933 0.84 ALOX5 (0.53) ENPP2ALDH1A1MAPTKMT2AHTT
SCHEMBL4354935 0.84 ALOX5 (0.53) ENPP2ALDH1A1MAPTKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 ENPP2 1946/4885ALDH1A1 284/4885MAPT 1470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.